세계의 천골신경 자극(SNS) 시장 규모는 2023년에 12억 달러로 평가되며, 예측 기간(2025-2032년)의 CAGR은 14.0%로, 2024년 13억 7,000만 달러에서 2032년에는 39억 달러로 성장할 전망입니다.
세계 천골신경자극(SNS) 시장은 요로감염(UTI), 과민성방광(OAB), 변실금 등의 증상을 포함한 절박성 요실금 발생률 증가로 인해 상승세를 보이고 있습니다. 환자의 방광과 장의 조절을 효과적으로 강화합니다. 미국에서는 약 1,300만 명의 성인이 요실금, 특히 여성에게 어려움을 겪고 있는 만큼, 안전하고 효과적인 해결책으로서 SNS의 매력은 분명합니다. 특히 영국 노인층에서 변실금 유병률이 증가하고 있는 것은 이러한 심각한 질환이 삶의 질과 사회적 상호작용에 큰 영향을 미치기 때문에 시장이 성장하고 있음을 시사합니다.
Global Sacral Nerve Stimulation (SNS) Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.37 billion in 2024 to USD 3.9 billion by 2032, growing at a CAGR of 14.0% during the forecast period (2025-2032).
The global Sacral Nerve Stimulation (SNS) market is on an upward trajectory, primarily driven by the rising incidence of urge incontinence, including conditions like Urinary Tract Infections (UTI), Overactive Bladder (OAB), and fecal incontinence. SNS technology involves implanting a device that sends electrical impulses to the sacral nerves, effectively enhancing bladder and bowel control in patients who have not found relief through traditional therapies. With around 13 million adults in the U.S. affected by urinary incontinence, predominantly women, the appeal of SNS as a safe and effective solution is evident. The increasing prevalence of fecal incontinence, particularly among the elderly in the UK, underscores a growing market, as this debilitating condition significantly impacts quality of life and social interaction.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sacral Nerve Stimulation (Sns) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Sacral Nerve Stimulation (SNS) Market Segmental Analysis
Global Sacral Nerve Stimulation (SNS) Market is segmented by Product, Application and region. Based on Product, the market is segmented into Implantable SNS Devices and External SNS Devices. Based on Application, the market is segmented into Urinary and Fecal Incontinence, Chronic Anal Fissure, Urge Incontinence and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Sacral Nerve Stimulation (SNS) Market
The global Sacral Nerve Stimulation (SNS) market is experiencing significant growth due to a surge in cases of urge incontinence, including conditions like Urinary Tract Infections (UTIs) and a rising incidence of Overactive Bladder (OAB) and fecal incontinence. SNS presents an effective treatment alternative for patients who have not found relief through conventional therapies or medications. The increasing prevalence of urinary and fecal disorders, especially among the elderly, propels the demand for SNS devices. This market driver is primarily motivated by the urgent need to enhance the quality of life for affected individuals, improve bladder function, and reduce the adverse effects of these issues on daily living.
Restraints in the Global Sacral Nerve Stimulation (SNS) Market
A notable restraint within the global Sacral Nerve Stimulation (SNS) market is the substantial financial burden associated with the devices and their associated procedures. The costs of procuring the SNS device, conducting the surgical implantation, and managing follow-up care and potential complications can deter both patients and healthcare providers from pursuing this treatment option. Furthermore, restrictive reimbursement policies and limitations set by healthcare payers exacerbate the issue, further restricting access to SNS therapies. This financial challenge can impede broader adoption and growth in the market, especially in regions that face healthcare resource limitations or economic constraints.
Market Trends of the Global Sacral Nerve Stimulation (SNS) Market
The Global Sacral Nerve Stimulation (SNS) market is witnessing a significant trend towards the adoption of miniaturization and wireless technology. Manufacturers are increasingly developing compact SNS devices that prioritize patient comfort and convenience, catering to the rising demand for minimally invasive treatments. This focus on smaller devices not only simplifies implantation procedures but also potentially diminishes post-operative complications. Additionally, the incorporation of wireless technology enhances patient monitoring and data collection, enabling remote programming and personalized treatment plans. As a result, this trend promises to reduce patients' reliance on frequent clinic visits, ultimately improving the overall treatment experience and outcomes in SNS therapy.